1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Ocular Inflammation Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Immunosuppressant 1.2.3 Monoclonal Antibodies 1.2.4 Corticosteroids 1.2.5 Cycloplegic Agents 1.2.6 Antibiotics 1.2.7 Analgesics 1.2.8 Antivirals 1.2.9 Antifungal 1.3 Market by Application 1.3.1 Global Ocular Inflammation Treatment Market Share by Application: 2020 VS 2026 1.3.2 Retail Pharmacies 1.3.3 Hospital Pharmacies 1.3.4 Online Pharmacies 1.3.5 Drug Stores 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Ocular Inflammation Treatment Market Perspective (2015-2026) 2.2 Global Ocular Inflammation Treatment Growth Trends by Regions 2.2.1 Ocular Inflammation Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Ocular Inflammation Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Ocular Inflammation Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Ocular Inflammation Treatment Players by Market Size 3.1.1 Global Top Ocular Inflammation Treatment Players by Revenue (2015-2020) 3.1.2 Global Ocular Inflammation Treatment Revenue Market Share by Players (2015-2020) 3.2 Global Ocular Inflammation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Ocular Inflammation Treatment Revenue 3.4 Global Ocular Inflammation Treatment Market Concentration Ratio 3.4.1 Global Ocular Inflammation Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Ocular Inflammation Treatment Revenue in 2019 3.5 Key Players Ocular Inflammation Treatment Area Served 3.6 Key Players Ocular Inflammation Treatment Product Solution and Service 3.7 Date of Enter into Ocular Inflammation Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Ocular Inflammation Treatment Breakdown Data by Type (2015-2026) 4.1 Global Ocular Inflammation Treatment Historic Market Size by Type (2015-2020) 4.2 Global Ocular Inflammation Treatment Forecasted Market Size by Type (2021-2026) 5 Ocular Inflammation Treatment Breakdown Data by Application (2015-2026) 5.1 Global Ocular Inflammation Treatment Historic Market Size by Application (2015-2020) 5.2 Global Ocular Inflammation Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Ocular Inflammation Treatment Market Size (2015-2026) 6.2 North America Ocular Inflammation Treatment Market Size by Type (2015-2020) 6.3 North America Ocular Inflammation Treatment Market Size by Application (2015-2020) 6.4 North America Ocular Inflammation Treatment Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Ocular Inflammation Treatment Market Size (2015-2026) 7.2 Europe Ocular Inflammation Treatment Market Size by Type (2015-2020) 7.3 Europe Ocular Inflammation Treatment Market Size by Application (2015-2020) 7.4 Europe Ocular Inflammation Treatment Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Ocular Inflammation Treatment Market Size (2015-2026) 8.2 China Ocular Inflammation Treatment Market Size by Type (2015-2020) 8.3 China Ocular Inflammation Treatment Market Size by Application (2015-2020) 8.4 China Ocular Inflammation Treatment Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Ocular Inflammation Treatment Market Size (2015-2026) 9.2 Japan Ocular Inflammation Treatment Market Size by Type (2015-2020) 9.3 Japan Ocular Inflammation Treatment Market Size by Application (2015-2020) 9.4 Japan Ocular Inflammation Treatment Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Ocular Inflammation Treatment Market Size (2015-2026) 10.2 Southeast Asia Ocular Inflammation Treatment Market Size by Type (2015-2020) 10.3 Southeast Asia Ocular Inflammation Treatment Market Size by Application (2015-2020) 10.4 Southeast Asia Ocular Inflammation Treatment Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Allergan Plc. 11.1.1 Allergan Plc. Company Details 11.1.2 Allergan Plc. Business Overview 11.1.3 Allergan Plc. Ocular Inflammation Treatment Introduction 11.1.4 Allergan Plc. Revenue in Ocular Inflammation Treatment Business (2015-2020)) 11.1.5 Allergan Plc. Recent Development 11.2 Cipla Ltd. 11.2.1 Cipla Ltd. Company Details 11.2.2 Cipla Ltd. Business Overview 11.2.3 Cipla Ltd. Ocular Inflammation Treatment Introduction 11.2.4 Cipla Ltd. Revenue in Ocular Inflammation Treatment Business (2015-2020) 11.2.5 Cipla Ltd. Recent Development 11.3 Pfizer, Inc. 11.3.1 Pfizer, Inc. Company Details 11.3.2 Pfizer, Inc. Business Overview 11.3.3 Pfizer, Inc. Ocular Inflammation Treatment Introduction 11.3.4 Pfizer, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) 11.3.5 Pfizer, Inc. Recent Development 11.4 Novartis AG 11.4.1 Novartis AG Company Details 11.4.2 Novartis AG Business Overview 11.4.3 Novartis AG Ocular Inflammation Treatment Introduction 11.4.4 Novartis AG Revenue in Ocular Inflammation Treatment Business (2015-2020) 11.4.5 Novartis AG Recent Development 11.5 Valeant Pharmaceuticals International, Inc. 11.5.1 Valeant Pharmaceuticals International, Inc. Company Details 11.5.2 Valeant Pharmaceuticals International, Inc. Business Overview 11.5.3 Valeant Pharmaceuticals International, Inc. Ocular Inflammation Treatment Introduction 11.5.4 Valeant Pharmaceuticals International, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) 11.5.5 Valeant Pharmaceuticals International, Inc. Recent Development 11.6 Alimera Sciences, Inc. 11.6.1 Alimera Sciences, Inc. Company Details 11.6.2 Alimera Sciences, Inc. Business Overview 11.6.3 Alimera Sciences, Inc. Ocular Inflammation Treatment Introduction 11.6.4 Alimera Sciences, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) 11.6.5 Alimera Sciences, Inc. Recent Development 11.7 Akorn, Inc. 11.7.1 Akorn, Inc. Company Details 11.7.2 Akorn, Inc. Business Overview 11.7.3 Akorn, Inc. Ocular Inflammation Treatment Introduction 11.7.4 Akorn, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) 11.7.5 Akorn, Inc. Recent Development 11.8 Abbvie, Inc. 11.8.1 Abbvie, Inc. Company Details 11.8.2 Abbvie, Inc. Business Overview 11.8.3 Abbvie, Inc. Ocular Inflammation Treatment Introduction 11.8.4 Abbvie, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) 11.8.5 Abbvie, Inc. Recent Development 11.9 Eyegate Pharmaceuticals, Inc. 11.9.1 Eyegate Pharmaceuticals, Inc. Company Details 11.9.2 Eyegate Pharmaceuticals, Inc. Business Overview 11.9.3 Eyegate Pharmaceuticals, Inc. Ocular Inflammation Treatment Introduction 11.9.4 Eyegate Pharmaceuticals, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) 11.9.5 Eyegate Pharmaceuticals, Inc. Recent Development 11.10 pSivida Corporation 11.10.1 pSivida Corporation Company Details 11.10.2 pSivida Corporation Business Overview 11.10.3 pSivida Corporation Ocular Inflammation Treatment Introduction 11.10.4 pSivida Corporation Revenue in Ocular Inflammation Treatment Business (2015-2020) 11.10.5 pSivida Corporation Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Ocular Inflammation Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Immunosuppressant Table 4. Key Players of Monoclonal Antibodies Table 5. Key Players of Corticosteroids Table 6. Key Players of Cycloplegic Agents Table 7. Key Players of Antibiotics Table 8. Key Players of Analgesics Table 9. Key Players of Antivirals Table 10. Key Players of Antifungal Table 11. Global Ocular Inflammation Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 12. Global Ocular Inflammation Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 13. Global Ocular Inflammation Treatment Market Size by Regions (2015-2020) (US$ Million) Table 14. Global Ocular Inflammation Treatment Market Share by Regions (2015-2020) Table 15. Global Ocular Inflammation Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 16. Global Ocular Inflammation Treatment Market Share by Regions (2021-2026) Table 17. Ocular Inflammation Treatment Market Market Trends Table 18. Ocular Inflammation Treatment Market Drivers Table 19. Ocular Inflammation Treatment Market Challenges Table 20. Ocular Inflammation Treatment Market Restraints Table 21. Global Ocular Inflammation Treatment Revenue by Players (2015-2020) (US$ Million) Table 22. Global Ocular Inflammation Treatment Market Share by Players (2015-2020) Table 23. Global Top Ocular Inflammation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Inflammation Treatment as of 2019) Table 24. Global Ocular Inflammation Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Ocular Inflammation Treatment Product Solution and Service Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Ocular Inflammation Treatment Market Size by Type (2015-2020) (US$ Million) Table 29. Global Ocular Inflammation Treatment Market Size Share by Type (2015-2020) Table 30. Global Ocular Inflammation Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Ocular Inflammation Treatment Market Size Share by Application (2015-2020) Table 32. Global Ocular Inflammation Treatment Market Size by Application (2015-2020) (US$ Million) Table 33. Global Ocular Inflammation Treatment Market Size Share by Application (2021-2026) Table 34. North America Ocular Inflammation Treatment Market Size by Type (2015-2020) (US$ Million) Table 35. North America Ocular Inflammation Treatment Market Share by Type (2015-2020) Table 36. North America Ocular Inflammation Treatment Market Size by Application (2015-2020) (US$ Million) Table 37. North America Ocular Inflammation Treatment Market Share by Application (2015-2020) Table 38. North America Ocular Inflammation Treatment Market Size by Country (US$ Million) (2015-2020) Table 39. North America Ocular Inflammation Treatment Market Share by Country (2015-2020) Table 40. Europe Ocular Inflammation Treatment Market Size by Type (2015-2020) (US$ Million) Table 41. Europe Ocular Inflammation Treatment Market Share by Type (2015-2020) Table 42. Europe Ocular Inflammation Treatment Market Size by Application (2015-2020) (US$ Million) Table 43. Europe Ocular Inflammation Treatment Market Share by Application (2015-2020) Table 44. Europe Ocular Inflammation Treatment Market Size by Country (US$ Million) (2015-2020) Table 45. Europe Ocular Inflammation Treatment Market Share by Country (2015-2020) Table 46. China Ocular Inflammation Treatment Market Size by Type (2015-2020) (US$ Million) Table 47. China Ocular Inflammation Treatment Market Share by Type (2015-2020) Table 48. China Ocular Inflammation Treatment Market Size by Application (2015-2020) (US$ Million) Table 49. China Ocular Inflammation Treatment Market Share by Application (2015-2020) Table 50. China Ocular Inflammation Treatment Market Size by Region (US$ Million) (2015-2020) Table 51. China Ocular Inflammation Treatment Market Share by Region (2015-2020) Table 52. Japan Ocular Inflammation Treatment Market Size by Type (2015-2020) (US$ Million) Table 53. Japan Ocular Inflammation Treatment Market Share by Type (2015-2020) Table 54. Japan Ocular Inflammation Treatment Market Size by Application (2015-2020) (US$ Million) Table 55. Japan Ocular Inflammation Treatment Market Share by Application (2015-2020) Table 56. Japan Ocular Inflammation Treatment Market Size by Country (US$ Million) (2015-2020) Table 57. Japan Ocular Inflammation Treatment Market Share by Country (2015-2020) Table 58. Southeast Asia Ocular Inflammation Treatment Market Size by Type (2015-2020) (US$ Million) Table 59. Southeast Asia Ocular Inflammation Treatment Market Share by Type (2015-2020) Table 60. Southeast Asia Ocular Inflammation Treatment Market Size by Application (2015-2020) (US$ Million) Table 61. Southeast Asia Ocular Inflammation Treatment Market Share by Application (2015-2020) Table 62. Southeast Asia Ocular Inflammation Treatment Market Size by Country (US$ Million) (2015-2020) Table 63. Southeast Asia Ocular Inflammation Treatment Market Share by Country (2015-2020) Table 64. Allergan Plc. Company Details Table 65. Allergan Plc. Business Overview Table 66. Allergan Plc. Product Table 67. Allergan Plc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (US$ Million) Table 68. Allergan Plc. Recent Development Table 69. Cipla Ltd. Company Details Table 70. Cipla Ltd. Business Overview Table 71. Cipla Ltd. Product Table 72. Cipla Ltd. Revenue in Ocular Inflammation Treatment Business (2015-2020) (US$ Million) Table 73. Cipla Ltd. Recent Development Table 74. Pfizer, Inc. Company Details Table 75. Pfizer, Inc. Business Overview Table 76. Pfizer, Inc. Product Table 77. Pfizer, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (US$ Million) Table 78. Pfizer, Inc. Recent Development Table 79. Novartis AG Company Details Table 80. Novartis AG Business Overview Table 81. Novartis AG Product Table 82. Novartis AG Revenue in Ocular Inflammation Treatment Business (2015-2020) (US$ Million) Table 83. Novartis AG Recent Development Table 84. Valeant Pharmaceuticals International, Inc. Company Details Table 85. Valeant Pharmaceuticals International, Inc. Business Overview Table 86. Valeant Pharmaceuticals International, Inc. Product Table 87. Valeant Pharmaceuticals International, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (US$ Million) Table 88. Valeant Pharmaceuticals International, Inc. Recent Development Table 89. Alimera Sciences, Inc. Company Details Table 90. Alimera Sciences, Inc. Business Overview Table 91. Alimera Sciences, Inc. Product Table 92. Alimera Sciences, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (US$ Million) Table 93. Alimera Sciences, Inc. Recent Development Table 94. Akorn, Inc. Company Details Table 95. Akorn, Inc. Business Overview Table 96. Akorn, Inc. Product Table 97. Akorn, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (US$ Million) Table 98. Akorn, Inc. Recent Development Table 99. Abbvie, Inc. Business Overview Table 100. Abbvie, Inc. Product Table 101. Abbvie, Inc. Company Details Table 102. Abbvie, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (US$ Million) Table 103. Abbvie, Inc. Recent Development Table 104. Eyegate Pharmaceuticals, Inc. Company Details Table 105. Eyegate Pharmaceuticals, Inc. Business Overview Table 106. Eyegate Pharmaceuticals, Inc. Product Table 107. Eyegate Pharmaceuticals, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (US$ Million) Table 108. Eyegate Pharmaceuticals, Inc. Recent Development Table 109. pSivida Corporation Company Details Table 110. pSivida Corporation Business Overview Table 111. pSivida Corporation Product Table 112. pSivida Corporation Revenue in Ocular Inflammation Treatment Business (2015-2020) (US$ Million) Table 113. pSivida Corporation Recent Development Table 114. Research Programs/Design for This Report Table 115. Key Data Information from Secondary Sources Table 116. Key Data Information from Primary Sources List of Figures Figure 1. Global Ocular Inflammation Treatment Market Share by Type: 2020 VS 2026 Figure 2. Immunosuppressant Features Figure 3. Monoclonal Antibodies Features Figure 4. Corticosteroids Features Figure 5. Cycloplegic Agents Features Figure 6. Antibiotics Features Figure 7. Analgesics Features Figure 8. Antivirals Features Figure 9. Antifungal Features Figure 10. Global Ocular Inflammation Treatment Market Share by Application: 2020 VS 2026 Figure 11. Retail Pharmacies Case Studies Figure 12. Hospital Pharmacies Case Studies Figure 13. Online Pharmacies Case Studies Figure 14. Drug Stores Case Studies Figure 15. Ocular Inflammation Treatment Report Years Considered Figure 16. Global Ocular Inflammation Treatment Market Size (US$ Million), YoY Growth 2015-2026 Figure 17. Global Ocular Inflammation Treatment Market Share by Regions: 2020 VS 2026 Figure 18. Global Ocular Inflammation Treatment Market Share by Regions (2021-2026) Figure 19. Global Ocular Inflammation Treatment Market Share by Players in 2019 Figure 20. Global Top Ocular Inflammation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Inflammation Treatment as of 2019 Figure 21. The Top 10 and 5 Players Market Share by Ocular Inflammation Treatment Revenue in 2019 Figure 22. North America Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. United States Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Canada Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Europe Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Germany Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. France Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. U.K. Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Italy Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Russia Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Nordic Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Rest of Europe Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Asia-Pacific Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. China Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Japan Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. South Korea Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Southeast Asia Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. India Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Australia Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Rest of Asia-Pacific Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Latin America Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Mexico Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Brazil Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Middle East & Africa Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Turkey Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 46. Saudi Arabia Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 47. UAE Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 48. Rest of Middle East & Africa Ocular Inflammation Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 49. Allergan Plc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2015-2020) Figure 50. Cipla Ltd. Revenue Growth Rate in Ocular Inflammation Treatment Business (2015-2020) Figure 51. Pfizer, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2015-2020) Figure 52. Novartis AG Revenue Growth Rate in Ocular Inflammation Treatment Business (2015-2020) Figure 53. Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2015-2020) Figure 54. Alimera Sciences, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2015-2020) Figure 55. Akorn, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2015-2020) Figure 56. Abbvie, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2015-2020) Figure 57. Eyegate Pharmaceuticals, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2015-2020) Figure 58. pSivida Corporation Revenue Growth Rate in Ocular Inflammation Treatment Business (2015-2020) Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

Allergan Plc. Cipla Ltd. Pfizer, Inc. Novartis AG Valeant Pharmaceuticals International, Inc. Alimera Sciences, Inc. Akorn, Inc. Abbvie, Inc. Eyegate Pharmaceuticals, Inc. pSivida Corporation